Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review

被引:9
作者
Roger, Claire [1 ,2 ]
机构
[1] Nimes Caremeau Univ Hosp, Dept Anesthesiol & Intens Care Pain & Emergency Me, Pl Prof Robert Debre, F-30029 Nimes 9, France
[2] Montpellier Univ, Fac Med, UR IMAGINE Initial Management & Prevent OrGan Fail, Montpellier, France
来源
JOURNAL OF INTENSIVE MEDICINE | 2024年 / 4卷 / 03期
关键词
Pharmacokinetics/pharmacodynamics; ICU; Antibiotics; Dose optimization; TDM; AUGMENTED RENAL CLEARANCE; CARE-UNIT PATIENTS; CEFEPIME PLASMA-CONCENTRATIONS; FEBRILE NEUTROPENIC PATIENTS; BETA-LACTAM ANTIBIOTICS; TARGET SITE PENETRATION; CONTINUOUS-INFUSION; POPULATION PHARMACOKINETICS; COLISTIN METHANESULFONATE; INTRAVENOUS FOSFOMYCIN;
D O I
10.1016/j.jointm.2023.12.007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Effective treatment of sepsis not only demands prompt administration of appropriate antimicrobials but also requires precise dosing to enhance the likelihood of patient survival. Adequate dosing refers to the administration of doses that yield therapeutic drug concentrations at the infection site. This ensures a favorable clinical and microbiological response while avoiding antibiotic-related toxicity. Therapeutic drug monitoring (TDM) is the recommended approach for attaining these goals. However, TDM is not universally available in all intensive care units (ICUs) and for all antimicrobial agents. In the absence of TDM, healthcare practitioners need to rely on several factors to make informed dosing decisions. These include the patient's clinical condition, causative pathogen, impact of organ dysfunction (requiring extracorporeal therapies), and physicochemical properties of the antimicrobials. In this context, the pharmacokinetics of antimicrobials vary considerably between different critically ill patients and within the same patient over the course of ICU stay. This variability underscores the need for individualized dosing. This review aimed to describe the main pathophysiological changes observed in critically ill patients and their impact on antimicrobial drug dosing decisions. It also aimed to provide essential practical recommendations that may aid clinicians in optimizing antimicrobial therapy among critically ill patients.
引用
收藏
页码:287 / 298
页数:12
相关论文
共 138 条
[31]   Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks [J].
Ehrentraut, Stefan Felix ;
Muenster, Stefan ;
Kreyer, Stefan ;
Theuerkauf, Nils Ulrich ;
Bode, Christian ;
Steinhagen, Folkert ;
Ehrentraut, Heidi ;
Schewe, Jens-Christian ;
Weber, Matthias ;
Putensen, Christian ;
Muders, Thomas .
MICROORGANISMS, 2020, 8 (03)
[32]   Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia [J].
Ehrmann, Stephan ;
Barbier, Francois ;
Demiselle, Julien ;
Quenot, Jean-Pierre ;
Herbrecht, Jean-Etienne ;
Roux, Damien ;
Lacherade, Jean-Claude ;
Landais, Mickael ;
Seguin, Philippe ;
Schnell, David ;
Veinstein, Anne ;
Gouin, Philippe ;
Lasocki, Sigismond ;
Lu, Qin ;
Beduneau, Gaetan ;
Ferrandiere, Martine ;
Plantefeve, Gaetan ;
Dahyot-Fizelier, Claire ;
Chebib, Nader ;
Mercier, Emmanuelle ;
Heuze-Vourc'h, Nathalie ;
Respaud, Renaud ;
Gregoire, Nicolas ;
Garot, Denis ;
Nay, Mai-Anh ;
Meziani, Ferhat ;
Andreu, Pascal ;
Clere-Jehl, Raphael ;
Zucman, Noemie ;
Azais, Marie-Ange ;
Saint-Martin, Marjorie ;
Gandonniere, Charlotte Salmon ;
Benzekri, Dalila ;
Merdji, Hamid ;
Tavernier, Elsa .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (22) :2052-2062
[33]   The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review [J].
Ewoldt, Tim M. J. ;
Abdulla, Alan ;
Hunfeld, Nicole ;
Li, Letao ;
Smeets, Tim J. L. ;
Gommers, Diederik ;
Koch, Birgit C. P. ;
Endeman, Henrik .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (06) :413-421
[34]   Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SATE) study [J].
Finfer, Simon ;
Bellomo, Rinaldo .
BRITISH MEDICAL JOURNAL, 2006, 333 (7577) :1044-1046
[35]   The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients [J].
Fiore, Marco ;
Peluso, Lorenzo ;
Taccone, Fabio Silvio ;
Hites, Maya .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (05) :543-554
[36]   Adverse events associated with intravenous fosfomycin [J].
Florent, Amelie ;
Chichmanian, Rose-Marie ;
Cua, Eric ;
Pulcini, Celine .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (01) :82-+
[37]   Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance [J].
Fratoni, Andrew J. ;
Mah, John W. ;
Nicolau, David P. ;
Kuti, Joseph L. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (11) :2992-2999
[38]   Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy [J].
Fugate, Jennifer E. ;
Kalimullah, Ejaaz A. ;
Hocker, Sara E. ;
Clark, Sarah L. ;
Wijdicks, Eelco F. M. ;
Rabinstein, Alejandro A. .
CRITICAL CARE, 2013, 17 (06)
[39]   Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia [J].
Gatti, Milo ;
Giannella, Maddalena ;
Rinaldi, Matteo ;
Gaibani, Paolo ;
Viale, Pierluigi ;
Pea, Federico .
ANTIBIOTICS-BASEL, 2022, 11 (12)
[40]   An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients [J].
Gatti, Milo ;
Viaggi, Bruno ;
Rossolini, Gian Maria ;
Pea, Federico ;
Viale, Pierluigi .
ANTIBIOTICS-BASEL, 2022, 11 (01)